N/A
N=102
Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
Laryngismus
Bottom Line
View on ClinicalTrials.gov: NCT01456299 ↗Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcome: Primary: LMA Insertion Condition — 14; 21; 24; 7 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Remifentanil 1 (Drug); Control (Drug); Remifentanil 2 (Drug)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Gachon University Gil Medical Center
- Primary completion
- Dec 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY LMA Insertion Condition |
14; 21; 24; 7; 5; 3 | — |
| SECONDARY Frequency of Apnea |
— | — |
Summary
The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Eligibility Criteria
Inclusion Criteria
- Adult patients, aged 18-60 with ASA physical status I or II, who were scheduled to minor elective surgery ( 30 kg/m2) and suspected difficult airway
Data sourced from ClinicalTrials.gov (NCT01456299). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.